FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Valeant Pharmaceuticals North America CLENZIderm M Recall

CLENZIderm M

Valeant Pharmaceuticals North America LLC · Bridgewater, NJ

Risk level
Class III
Reported by FDA
Apr 26, 2017
Recall ID
D-0673-2017
Check your lot numberHow we source this data

Summary

Valeant Pharmaceuticals North America recalled CLENZIderm M starting Mar 20, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0673-2017 on Apr 26, 2017. Reason: Discoloration. Status: Terminated.

Why it was recalled

Discoloration.

Product description

CLENZIderm M.D. Acne Treatment System, kit has 3 bottles a) Therapeutic Lotion (benzoyl peroxide 5% Acne Treatment) 47mL bottle, b) Daily Care Foaming Cleanser (Salicylic Acid 2% Acne Treatment) 118 mL bottle, c) Salicylic Acid 2% Acne Treatment 148mL, Valeant Pharmaceuticals North America LLC Distributed by OMP, Inc Long Beach, CA 90806 Made in USA, Product SKU 301876103018, NDC 0187-6103-01

Lot numbers, UPCs & expiration codes

Lot #: a) 15I1234, Exp. 09/18, b) 15E1221, Exp. 09/18, c) 15G1235 and 15I1236, Exp. 09/18.

Where it was sold

nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0673-2017
Classification
Class III
Status
Terminated
Recall initiated
Mar 20, 2017
FDA report date
Apr 26, 2017
Quantity
5,647 units
Recall type
Voluntary: Firm initiated
Recalling firm
Valeant Pharmaceuticals North America LLC

Original FDA data

Every field from FDA enforcement report D-0673-2017, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
76743
Address
400 Somerset Corporate Blvd
Code information
Lot #: a) 15I1234, Exp. 09/18, b) 15E1221, Exp. 09/18, c) 15G1235 and 15I1236, Exp. 09/18.
Postal code
08807-2867
Report date
Apr 26, 2017
Product type
Drugs
Recall number
D-0673-2017
Classification
Class III
Recalling firm
Valeant Pharmaceuticals North America LLC
Product quantity
5,647 units
Termination date
Jun 14, 2019
Reason for recall
Discoloration.
Voluntary / mandated
Voluntary: Firm initiated
Product description
CLENZIderm M.D. Acne Treatment System, kit has 3 bottles a) Therapeutic Lotion (benzoyl peroxide 5% Acne Treatment) 47mL bottle, b) Daily Care Foaming Cleanser (Salicylic Acid 2% Acne Treatment) 118 mL bottle, c) Salicylic Acid 2% Acne Treatment 148mL, Valeant Pharmaceuticals North America LLC Distributed by OMP, Inc Long Beach, CA 90806 Made in USA, Product SKU 301876103018, NDC 0187-6103-01
Distribution pattern
nationwide
Recall initiation date
Mar 20, 2017
Initial firm notification
Letter
Center classification date
Apr 17, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0673-2017, published Apr 26, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls